[1] Deerenberg EB, Timmermans L, Hogerzeil DP, et al.A systematic review of the surgical treatment of large incisional hernia[J]. Hernia,2015,19(1):89-101.
[2] Nguyen V, Shestak KC.Separation of anatomic components method of abdominal wall reconstruction-clinical outcome analysis and an update of surgical modifications using the technique[J]. Clin Plast Surg,2006,33(2):247-257.
[3] Ramirez OM, Ruas E, Dellon AL.“Components separation” method for closure of abdominal-wall defects: an anatomic and clinical study[J]. Plast Reconstr Surg,1990, 86(3):519-526.
[4] Novitsky YW, Elliott HL, Orenstein SB, et al.Transversus abdominis muscle release: a novel approach to posterior component separation during complex abdominal wall reconstruction[J]. Am J Surg,2012,204(5):709-716.
[5] Dressler D.Clinical applications of botulinum toxin[J]. Curr Opin Microbiol,2012,15(3):325-336.
[6] 朱力, 王恒樑, 黄留玉. 肉毒毒素研究进展[J]. 生物技术通讯,2005,16(2):186-190.
[7] Won CH, Lee HM, Lee WS, et al.Efficacy and safety of a novel botulinum toxin type a product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study[J]. Dermatol Surg,2013,39(1 pt2):171-178.
[8] Smoot D, Zielinski M, Jenkins D, et al.Botox A injection for pain after laparoscopic ventral hernia: a case report[J]. Pain Med,2011,12(7):1121-1123.
[9] Ibarra-Hurtado TR, Nuño-Guzmán CM.Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen[J]. Hernia,2013,17(1):101-107.
[10] Ibarra-Hurtado TR, Nuño-Guzmán CM, Echeagaray-Herrera JE, et al.Use of botulinum toxin type a before abdominal wall hernia reconstruction[J]. World J Surg,2009,33(12):2553-2556.
[11] Cakmak M, Caglayan F, Somuncu S, et al.Effect of paralysis of the abdominal wall muscles by botulinum A toxin to intraabdominal pressure: an experimental study[J]. J Pediatr Surg,2006,41(4):821-825.
[12] Weissler JM, Lanni MA, Tecce MG, et al.Chemical component separation: a systematic review and meta-analysis of botulinum toxin for management of ventral hernia[J]. J Plast Surg Hand Surg,2017,51(5):366-374.
[13] Elstner KE, Jacombs AS, Read JW, et al.Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using Botulinum Toxin A[J]. Hernia,2016,20(2):209-219.
[14] Zendejas B, Khasawneh MA, Srvantstyan B, et al.Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs[J]. World J Surg,2013, 37(12):2830-2837.
[15] Farooque F, Jacombs AS, Roussos E, et al.Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair[J]. ANZ J Surg, 2016,86(1-2):79-83.
[16] Ibarra-Hurtado TR, Nuño-Guzmán CM, Miranda-Díaz AG, et al.Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management[J]. Hernia,2014,18(5):647-652.
[17] Zendejas B, Khasawneh MA, Srvantstyan B, et al.Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs[J]. World J Surg,2013, 37(12):2830-2837.
[18] Bueno-Lledó J, Torregrosa A, Ballester N, et al.Preope-rative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia[J]. Hernia,2017,21(2):233-243.
[19] Elstner KE, Read JW, Rodriguez-Acevedo O, et al.Preoperative progressive pneumoperitoneum complementing chemical component relaxation in complex ventral hernia repair[J]. Surg Endosc,2016,31(4):1-9.
[20] Smoot D, Zielinski M, Jenkins D, et al.Botox A injection for pain after laparoscopic ventral hernia: a case report[J]. Pain Medicine,2011,12(7):1121-1123.
[21] 王平, 吴浩, 黄永刚, 等. 化学性组织结构分离术治疗巨大切口疝一例[J]. 中华疝和腹壁外科杂志,2018,12(1):65-67.
